(CLARI) Clariane SE - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010386334

CLARI: Care, Nursing, Housing, Home, Support, Services

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France. Web URL: https://www.clariane.com

Additional Sources for CLARI Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CLARI Stock Overview

Market Cap in USD 790m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

CLARI Stock Ratings

Growth 5y -75.3%
Fundamental 21.8%
Dividend 2.11%
Rel. Strength Industry 1863
Analysts -
Fair Price Momentum 1.72 EUR
Fair Price DCF 31.73 EUR

CLARI Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 69.5%

CLARI Growth Ratios

Growth Correlation 3m 19.6%
Growth Correlation 12m 47.6%
Growth Correlation 5y -91.3%
CAGR 5y -36.65%
CAGR/Mean DD 5y -0.62
Sharpe Ratio 12m 0.82
Alpha 27.87
Beta 0.71
Volatility 57.22%
Current Volume 1171.2k
Average Volume 20d 971.6k
What is the price of CLARI stocks?
As of January 22, 2025, the stock is trading at EUR 2.21 with a total of 1,171,151 shares traded.
Over the past week, the price has changed by +19.16%, over one month by +16.27%, over three months by +38.17% and over the past year by +65.75%.
Is Clariane SE a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Clariane SE is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLARI as of January 2025 is 1.72. This means that CLARI is currently overvalued and has a potential downside of -22.17%.
Is CLARI a buy, sell or hold?
Clariane SE has no consensus analysts rating.
What are the forecast for CLARI stock price target?
According to ValueRays Forecast Model, CLARI Clariane SE will be worth about 1.9 in January 2026. The stock is currently trading at 2.21. This means that the stock has a potential downside of -15.84%.
Issuer Forecast Upside
Wallstreet Target Price 2 -7.7%
Analysts Target Price - -
ValueRay Target Price 1.9 -15.8%